Provided by Tiger Trade Technology Pte. Ltd.

Fidelity Disruptive Medicine ETF

31.67
-0.3613-1.13%
Volume:4K
Turnover:119.21K
Market Cap:51.43M
PE:- -
High:31.84
Open:31.84
Low:31.55
Close:32.03
52wk High:32.89
52wk Low:23.48
Shares:1.62M
Float Shares:1.62M
Volume Ratio:0.89
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

After Forte acquisition, H.C. Wainwright says First Tracks could be target

TIPRANKS
·
Jul 28

Midday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop

TIPRANKS
·
Jul 27

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Omeros (OMER)

TIPRANKS
·
Jul 27

European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading

MT Newswires Live
·
Jul 27

Wedbush Raises Price Target on Argenx to $1,050 From $1,000, Maintains Outperform Rating

MT Newswires Live
·
Jul 27

Masimo Receives FDA 510(k) Clearance for the Pediatric Patient State Index, the First-And-Only Sedation Score Specifically Designed for the Unique Physiology of the Pediatric Brain

Reuters
·
Jul 27

Argenx is Maintained at Neutral by Baird

Dow Jones
·
Jul 27

Argenx price target raised to $932 from $867 at Baird

TIPRANKS
·
Jul 27

Why Thermo Fisher Scientific (TMO) Is Up 6.7% After Q2 Beat, Buyback Completion, And InstaFlux Launch

Simply Wall St.
·
Jul 27

Revvity Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 25

Steris PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 25

Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets

Benzinga Earnings
·
Jul 25

Argenx's Vyvgart Beat Impressive With Focus On Upcoming Myositis Data, RBC says

MT Newswires Live
·
Jul 25

Thermo Fisher Scientific's Strong Q2 Not Enough to 'Meaningfully' Change H2 Outlook, RBC Says

MT Newswires Live
·
Jul 25

Thermo Fisher is Maintained at Overweight by Barclays

Dow Jones
·
Jul 24

Danaher’s recent volatility presents buying opportunity, says Argus

TIPRANKS
·
Jul 24

Argenx is Maintained at Market Outperform by Citizens

Dow Jones
·
Jul 24

RBC Raises Price Target on argenx to $1,025 From $945, Keeps Outperform Rating

MT Newswires Live
·
Jul 24

Argenx Se : Leerink Partners Raises Target Price to $1065 from $955

THOMSON REUTERS
·
Jul 24

Lifestance Health Group is Maintained at Buy by BTIG

Dow Jones
·
Jul 24